Trial Profile

Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 12 Dec 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hexasodium fytate (Primary)
Indications Calciphylaxis
Focus Proof of concept; Therapeutic Use
Sponsors Laboratoris Sanifit

Most Recent Events

25 May 2018 According to a Laboratoris Sanifit S.L. media release, results from this trial will be presented at the 55th ERA-EDTA Congress, Copenhagen, Denmark (from 24th-27th May 2018).
25 May 2018 Results published in a Laboratoris Sanifit S.L. media release.
06 Mar 2018 Primary endpoint (Wound Healing:Assessment of lesion score using Bates-Jensen wound assessment tool) has been met, according to a Sanifit media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com